These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 10772716)

  • 1. Synthesis of biomimetic analogs of neomycin B: potential inhibitors of the HIV RNA Rev response element.
    Nishizono N; Nair V
    Nucleosides Nucleotides Nucleic Acids; 2000; 19(1-2):283-95. PubMed ID: 10772716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Synthesis of biomimetic analogs of neomycin B].
    Nishizono N
    Yakugaku Zasshi; 2002 Jul; 122(7):465-9. PubMed ID: 12136642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of neomycin analogues for HIV-1 RRE RNA recognition identifies enhanced activity simplified neamine analogues.
    Simon B; Walmsley C; Jackson VJ; Garvey EP; Slater MJ; Berrisford DJ; Gardiner JM
    Bioorg Med Chem Lett; 2019 Jan; 29(2):339-341. PubMed ID: 30477891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neamine derivatives having a nucleobase with a lysine or an arginine as a linker, their synthesis and evaluation as potential inhibitors for HIV TAR-Tat.
    Yajima S; Shionoya H; Akagi T; Hamasaki K
    Bioorg Med Chem; 2006 Apr; 14(8):2799-809. PubMed ID: 16413787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trisaccharide mimetics of the aminoglycoside antibiotic neomycin.
    Rao Y; Venot A; Swayze EE; Griffey RH; Boons GJ
    Org Biomol Chem; 2006 Apr; 4(7):1328-37. PubMed ID: 16557321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluorescence-based methods for evaluating the RNA affinity and specificity of HIV-1 Rev-RRE inhibitors.
    Luedtke NW; Tor Y
    Biopolymers; 2003 Sep; 70(1):103-19. PubMed ID: 12925996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of HIV-1 Rev-RRE interaction by diphenylfuran derivatives.
    Ratmeyer L; Zapp ML; Green MR; Vinayak R; Kumar A; Boykin DW; Wilson WD
    Biochemistry; 1996 Oct; 35(42):13689-96. PubMed ID: 8885849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of a neamine dimer targeting the dimerization initiation site of HIV-1 RNA.
    Bodlenner A; Alix A; Weibel JM; Pale P; Ennifar E; Paillart JC; Walter P; Marquet R; Dumas P
    Org Lett; 2007 Oct; 9(22):4415-8. PubMed ID: 17915882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of HIV Rev peptides with the Rev response element RNA.
    Williamson JR; Battiste JL; Mao H; Frankel AD
    Nucleic Acids Symp Ser; 1995; (33):46-8. PubMed ID: 8643394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNA-ligand interactions: affinity and specificity of aminoglycoside dimers and acridine conjugates to the HIV-1 Rev response element.
    Luedtke NW; Liu Q; Tor Y
    Biochemistry; 2003 Oct; 42(39):11391-403. PubMed ID: 14516190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of mismatch-binding ligands as inhibitors for Rev-RRE interaction.
    Nakatani K; Horie S; Goto Y; Kobori A; Hagihara S
    Bioorg Med Chem; 2006 Aug; 14(15):5384-8. PubMed ID: 16603366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and evaluation of novel neamine derivatives effectively targeting to RNA.
    Xu Y; Jin H; Yang Z; Zhang L; Wang Q; Li M; Zhang L
    Bioorg Med Chem Lett; 2009 Apr; 19(8):2103-6. PubMed ID: 19327991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative analysis of shape-specific interactions of Rev response element with a positively charged Rev peptide by capillary electrophoresis.
    Han KC; Yu J; Yang EG
    Electrophoresis; 2005 Nov; 26(22):4379-86. PubMed ID: 16240294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potent inhibition of HIV-1 replication by backbone cyclic peptides bearing the Rev arginine rich motif.
    Chaloin L; Smagulova F; Hariton-Gazal E; Briant L; Loyter A; Devaux C
    J Biomed Sci; 2007 Sep; 14(5):565-84. PubMed ID: 17520355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exchange of the basic domain of human immunodeficiency virus type 1 Rev for a polyarginine stretch expands the RNA binding specificity, and a minimal arginine cluster is required for optimal RRE RNA binding affinity, nuclear accumulation, and trans-activation.
    Nam YS; Petrovic A; Jeong KS; Venkatesan S
    J Virol; 2001 Mar; 75(6):2957-71. PubMed ID: 11222721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural change in Rev responsive element RNA of HIV-1 on binding Rev peptide.
    Peterson RD; Feigon J
    J Mol Biol; 1996 Dec; 264(5):863-77. PubMed ID: 9000617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specificity in the binding of aminoglycosides to HIV-RRE RNA.
    Cho J; Rando RR
    Biochemistry; 1999 Jun; 38(26):8548-54. PubMed ID: 10387102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neamine dimers targeting the HIV-1 TAR RNA.
    Riguet E; Désiré J; Boden O; Ludwig V; Göbel M; Bailly C; Décout JL
    Bioorg Med Chem Lett; 2005 Nov; 15(21):4651-5. PubMed ID: 16153833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Branched aminoglycosides: biochemical studies and antibacterial activity of neomycin B derivatives.
    Hainrichson M; Pokrovskaya V; Shallom-Shezifi D; Fridman M; Belakhov V; Shachar D; Yaron S; Baasov T
    Bioorg Med Chem; 2005 Oct; 13(20):5797-807. PubMed ID: 15993084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacterial RNase P RNA is a drug target for aminoglycoside-arginine conjugates.
    Berchanski A; Lapidot A
    Bioconjug Chem; 2008 Sep; 19(9):1896-906. PubMed ID: 18712898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.